CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. Recall
CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. Model Number: 828820. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.
FDA recall Class II
Ongoing
FDA lists this Class II recall for CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0979-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Dec 16, 2024
- FDA report date
- Jan 29, 2025
- Quantity in commerce
- 46 units
- Distribution
- See key details
- FDA cause
- Labeling Change Control
What is being recalled?
CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. Model Number: 828820. Implantable device that provides constant intraventricular pressure and drainage of CSF for the management of hydrocephalus.
Affected model & UDI checker
Search the exact identifiers published for Z-0979-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 828820 | CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. | Check source notice | Not specified |
| Not specified | CODMAN CERTAS Plus Programmable Valve Right Angle Valve Only. | Check source notice | 10381780535997 |
FDA code information
UDI-DI: 10381780535997. Lot Number: 7415567.
Why was this product recalled?
Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Integra Lifesciences Corp. take?
Integra LifeSciences notified consignees on about 12/16/2024 via letter. Consignees were instructed to review and understand the information provided in the letter, complete and return the provided Customer Acknowledgement Form, remove any affected units from service and quarantine them, arrange for return of affected units, and forward the notification to anyone who utilizes the affected units. Distributors were instructed to follow the same directions but also requested to notify any customers if product was further distributed, and return affected units.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0979-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology